firing to optimize staple formation and transection. With real-time monitoring of over 1,000 measurements per second, these staplers help achieve a secure and consistent staple line. The staplers use the same reloads (gray, white, blue, green, and black) as the multi-port SureForm 45 staplers.
34
First Quarter 2025 Operational and Financial Highlights
•
Total revenue increased by 19% to $2.25 billion for the three months ended March 31, 2025, compared to $1.89 billion for the three months ended March 31, 2024.
•
Approximately 732,000
da Vinci procedures were performed during the three months ended March 31, 2025, an increase of 17% compared to approximately 627,000 da Vinci procedures for the three months ended March 31, 2024.
•
Approximately 30,700 Ion procedures were performed during the three months ended March 31, 2025, an increase of 58% compared to approximately 19,500 Ion procedures for the three months ended March 31, 2024.
•
Instruments and accessories revenue increased by 18% to $1.37 billion for the three months ended March 31, 2025, compared to $1.16 billion for the three months ended March 31, 2024.
•
Systems revenue increased by 25% to $523 million for the three months ended March 31, 2025, compared to $418 million during the three months ended March 31, 2024.
•
During the three months ended March 31, 2025, we placed 367 da Vinci surgical systems compared to 313 systems during the three months ended March 31, 2024. The first quarter 2025 da Vinci surgical system placements included 147 da Vinci 5 systems compared to 8 systems during the three months ended March 31, 2024.
•
As of March 31, 2025, we had a da Vinci surgical system installed base of approximately 10,189 systems, an increase of 15% compared to an installed base of approximately 8,887 systems as of March 31, 2024.
•
Utilization of da Vinci surgical systems, measured in terms of procedures per system per year, increased 2% relative to the first quarter of 2024.
•
During the three months ended March 31, 2025, we placed 49 Ion systems compared to 70 systems during the three months ended March 31, 2024.
•
As of March 31, 2025, we had an Ion system installed base of approximately 853 systems, an increase of 41% compared to an installed base of approximately 604 systems as of March 31, 2024.
•
Gross profit as a percentage of revenue was 64.7% for the three months ended March 31, 2025, compared to 65.9% for the three months ended March 31, 2024.
•
Operating income increased by 23% to $578 million for the three months ended March 31, 2025, compared to $469 million during the three months ended March 31, 2024. Operating income included $190 million and $156 million of share-based compensation expense related to employee stock plans and $8.5 million and $5.1 million of intangible asset-related charges for the three months ended March 31, 2025, and 2024, respectively.
•
As of March 31, 2025, we had $9.10 billion in cash, cash equivalents, and investments. Cash, cash equivalents, and